News 25th April 2024 BerGenBio ASA: New share capital registered 17th April 2024 BerGenBio ASA: Resolution to increase the share capital for settlement of underwriting commission 16th April 2024 BerGenBio ASA: Final results for the last exercise period for warrants issued in connection with rights issue 15th April 2024 BerGenBio ASA: Mandatory notification of trade by primary insiders and close associates 15th April 2024 BerGenBio ASA: Last day of the last exercise period for warrants issued in connection with rights issue 8th April 2024 BerGenBio ASA: Last day of trading in warrants 3rd April 2024 BerGenBio ASA: Information about the last exercise period for Warrants issued in connection with rights issue 2nd April 2024 BerGenBio ASA: Commencement of the last exercise period for warrants issued in connection with rights issue 2nd April 2024 BerGenBio ASA secures underwriting of NOK 118 million gross proceeds representing minimum 80% exercise of the remaining Warrants, providing funding into 2H 2025 Load more